Mr. Azar, a former drug company executive, immediately confronts two huge challenges: how to rein in drug prices and how to administer the Affordable Care Act.
The Trump administration has unveiled a Medicare program that closely resembles the Obama-era efforts to change the way doctors and hospitals are paid.
Efforts by Republicans to chip away at the Affordable Care Act, culminating in the repeal of the individual mandate, have left behind a more government-focused health program.
The tax bill headed for passage eliminates the Affordable Care Act’s mandate that most people have insurance. No one is sure what that will do to health care.
In Virginia, premiums on policies sold under the Affordable Care Act are pushing health coverage out of reach, and customers see political forces at work.